Menu
Currency
GWAS Study

Genome-wide association and linkage study in the Amish detects a novel candidate late-onset Alzheimer disease gene.

Cummings AC, Jiang L, Velez Edwards DR et al.

22881374 PubMed ID
GWAS Study Type
798 Participants
64 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CA
Cummings AC
JL
Jiang L
VE
Velez Edwards DR
MJ
McCauley JL
LR
Laux R
ML
McFarland LL
FD
Fuzzell D
KC
Knebusch C
CL
Caywood L
RL
Reinhart-Mercer L
NL
Nations L
GJ
Gilbert JR
KI
Konidari I
TM
Tramontana M
CM
Cuccaro ML
SW
Scott WK
PM
Pericak-Vance MA
HJ
Haines JL
Chapter II

Abstract

Summary of the research findings

To identify novel late-onset Alzheimer disease (LOAD) risk genes, we have analysed Amish populations of Ohio and Indiana. We performed genome-wide SNP linkage and association studies on 798 individuals (109 with LOAD). We tested association using the Modified Quasi-Likelihood Score test and also performed two-point and multipoint linkage analyses. We found that LOAD was significantly associated with APOE (P= 9.0 × 10-6) in all our ascertainment regions except for the Adams County, Indiana, community (P= 0.55). Genome-wide, the most strongly associated SNP was rs12361953 (P= 7.92 × 10-7). A very strong, genome-wide significant multipoint peak [recessive heterogeneity multipoint LOD (HLOD) = 6.14, dominant HLOD = 6.05] was detected on 2p12. Three additional loci with multipoint HLOD scores >3 were detected on 3q26, 9q31 and 18p11. Converging linkage and association results, the most significantly associated SNP under the 2p12 peak was at rs2974151 (P= 1.29 × 10-4). This SNP is located in CTNNA2, which encodes catenin alpha 2, a neuronal-specific catenin known to have function in the developing brain. These results identify CTNNA2 as a novel candidate LOAD gene, and implicate three other regions of the genome as novel LOAD loci. These results underscore the utility of using family-based linkage and association analyses in isolated populations to identify novel loci for traits with complex genetic architecture.

109 Amish cases, 689 Amish controls

Chapter III

Study Statistics

Key metrics and study information

798
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.